Autoimmune hepatitis and primary biliary cholangitis were markedly more common, with adjusted odds over sevenfold and fourfold higher, respectively, and risks were even greater in those positive for anti-tTG antibodies. This evidence concerns the gene TGM2 and autoimmune hepatitis.